These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8230733)

  • 1. [Clinical evaluation and pharmacology of DQ-2556 in the patients with compromised renal function].
    Aoki N; Usuda Y; Koda Y; Takasawa T; Wakabayashi N; Hayashi S; Nitta I; Honma C; Watanabe K
    Jpn J Antibiot; 1993 Aug; 46(8):637-46. PubMed ID: 8230733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical pharmacology and efficacy of S-1108].
    Aoki N; Usuda Y; Koda Y; Takasawa T; Wakabayashi N; Hayashi S; Nitta I; Kourakata Y; Watanabe K; Honma Y
    Jpn J Antibiot; 1993 Dec; 46(12):1063-74. PubMed ID: 8107269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fundamental and clinical evaluation of cefozopran in low birth weight infants and neonates].
    Sato Y; Sunakawa K; Akita H; Iwata S; Yokota T; Kusumoto Y
    Jpn J Antibiot; 1997 Dec; 50(12):917-35. PubMed ID: 9545669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran].
    Fujii R; Abe T; Tajima T; Terashima I; Meguro H; Nakazawa S; Sato H; Niinou K; Sunakawa K; Yokota T
    Jpn J Antibiot; 1994 Jan; 47(1):102-23. PubMed ID: 8114268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical pharmacology and efficacy of levofloxacin in elderly patients].
    Aoki N; Usuda Y; Koda Y; Takasawa T; Wakabayashi N; Hayashi S; Nitta I; Honma C; Watanabe K
    Jpn J Antibiot; 1992 May; 45(5):530-8. PubMed ID: 1512939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic and clinical studies with cefluprenam in the pediatric field. Pediatric Study Group of Gefluprenam].
    Fujii R; Abe T; Tajima T; Kobayashi M; Terashima I; Meguro H; Sunakawa K; Yokota T; Akita H; Kusumoto Y; Iwata S; Satoh Y; Toyonaga Y; Ishihara T; Nakamura H; Iwai N; Nakamura H; Kuno K; Katoh T; Ogawa A; Itomi K; Okumura A; Hayakawa F; Takahashi H; Etoh M
    Jpn J Antibiot; 1997 Jul; 50(7):597-621. PubMed ID: 9743906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies and sputum levels of ceftriaxone once daily administration in respiratory tract infection].
    Kuwabara M; Sasaki H; Fukuhara H; Arita H; Inamizu T; Sadamoto K; Kimura T; Yamane K; Shigemoto M; Kawamoto M
    Jpn J Antibiot; 1989 Apr; 42(4):921-9. PubMed ID: 2671426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency.
    Haubitz M; Bohnenstengel F; Brunkhorst R; Schwab M; Hofmann U; Busse D
    Kidney Int; 2002 Apr; 61(4):1495-501. PubMed ID: 11918757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical results and pharmacokinetics of 6059-S in the field of pediatrics (author's transl)].
    Takimoto M; Kusunoki Y; Chou K; Yoshioka H; Sanae N; Maruyama S
    Jpn J Antibiot; 1981 Apr; 34(4):545-50. PubMed ID: 6457162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic and clinical studies on DQ-2556 in the gynecological field].
    Yasuda J; Yamamoto T; Okada H
    Jpn J Antibiot; 1993 Jan; 46(1):67-74. PubMed ID: 8455333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory and clinical evaluations of flomoxef sodium in neonates].
    Iwai N; Nakamura H; Miyazu M; Kasai K; Watanabe Y; Taneda Y; Ozaki T; Matsui S; Maki T; Tauchi N
    Jpn J Antibiot; 1991 Nov; 44(11):1265-85. PubMed ID: 1784077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flomoxef in neonates and young infants; clinical efficacy, pharmacokinetic evaluation and effect on the intestinal bacterial flora].
    Fujita K; Murono K; Saijyo M; Kakuya F; Yoshioka H; Maruyama S; Sakata H; Hiramoto A; Inyaku F
    Jpn J Antibiot; 1991 Nov; 44(11):1216-27. PubMed ID: 1784072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A series of pharmacokinetic studies of ceftaroline fosamil in select populations: normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis.
    Riccobene T; Jakate A; Rank D
    J Clin Pharmacol; 2014 Jul; 54(7):742-52. PubMed ID: 24431097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fundamental and clinical studies of ceftazidime, a new cephem antibiotic in the field of pediatrics].
    Nakazawa S; Sato H; Niino K; Hirama Y; Narita A; Suzuki H; Nakazawa S; Chikaoka H; Tazoe K; Nakada Y
    Jpn J Antibiot; 1984 Mar; 37(3):407-22. PubMed ID: 6376853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis.
    Mistry GC; Majumdar AK; Swan S; Sica D; Fisher A; Xu Y; Hesney M; Xi L; Wagner JA; Deutsch PJ
    J Clin Pharmacol; 2006 Oct; 46(10):1128-38. PubMed ID: 16988201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlinear pharmacokinetics of DQ-2556, a new 3-quaternary ammonium cephalosporin antibiotic, in rats caused by non-Michaelis-Menten type, dose-dependent renal clearance.
    Matsubayashi K; Shintani S; Yoshida K; Yamada M; Tachizawa H
    J Pharm Sci; 1994 Feb; 83(2):186-92. PubMed ID: 8169786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial activity, pharmacokinetics and clinical use of a new cephalosporin antibiotic cephacetrile].
    Brogard JM; Kuntzmann F; Lavillaureix J
    Arzneimittelforschung; 1974 Sep; 24(9b):1528-33. PubMed ID: 4479819
    [No Abstract]   [Full Text] [Related]  

  • 18. [Basic and clinical studies on cefditoren pivoxil in pediatric field].
    Motohiro T; Handa S; Yamada S; Oki S; Yoshinaga Y; Sasaki H; Aramaki M; Oda K; Sakata Y; Kato H
    Jpn J Antibiot; 1994 Apr; 47(4):409-27. PubMed ID: 8201769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimum dose study of cefozopran in the pediatric field].
    Fujii R; Sunakawa K; Sato Y; Yokota T; Yoshimura K; Kondoh Y; Kawaoi Y; Terashima I; Meguro H; Niinou K; Toyonaga Y; Ishihara T; Iwai N; Nakamura H; Kuno K; Miyajima Y; Sakurai M; Itoh M; Kawasaki H; Suga S; Kamiya H; Fujiwara T; Inui T; Taniguchi K; Nakayama M
    Jpn J Antibiot; 1996 Jul; 49(7):663-77. PubMed ID: 8828069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics and clinical studies on flomoxef in neonates and premature infants. A study of flomoxef in the perinatal collaboration research group].
    Fujii R; Fujita K; Murono K; Saijo M; Kakuya F; Yoshioka H; Maruyama S; Sakata H; Hiramoto A; Inyaku F
    Jpn J Antibiot; 1993 Jul; 46(7):518-38. PubMed ID: 8371489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.